Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • OUTLOOK

Why big pharma has abandoned antibiotics

A lack of financial incentive has meant large pharmaceutical companies have left the market
  1. Benjamin Plackett

    1. Benjamin Plackett is a freelance writer in London.

    View author publications

    You can also search for this author in PubMed  Google Scholar

When scientists, public-health bodies and governments around the world warn that antimicrobial resistance is the next great health crisis, they have good reason. Since the 1960s, bacteria and other microorganisms have become increasingly resistant to antimicrobial drugs, leading to more and more people dying.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 586, S50-S52 (2020)

doi: https://doi.org/10.1038/d41586-020-02884-3

This article is part of Nature Outlook: Antimicrobial resistance, an editorially independent supplement produced with the financial support of third parties. About this content.

References

  1. Towse, A. et al. Health Policy 121, 1025–1030 (2017).

    Article  PubMed  Google Scholar 

  2. Kuo, Y.-T. et al. Lancet Gastroenterol. Hepatol. 2, 707–715 (2017).

    Article  PubMed  Google Scholar 

  3. Roope, L. S. J. et al. Science 364, eaau4679 (2019).

    Article  PubMed  Google Scholar 

  4. Sharma, P. & Towse, A. New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy Options (OHE, 2014).

    Google Scholar 

  5. Projan, S. J. et al. Curr. Opin. Microbiol. 6, 427–430 (2003).

    Article  PubMed  Google Scholar 

  6. Stokes, J. M. et al. Cell 180, 688–702 (2020).

    Article  PubMed  Google Scholar 

  7. Enne, V. I., Livermore, D. M., Stephens, P. & Hall, L. M. C. Lancet 357, 1325–1328 (2001).

    Article  PubMed  Google Scholar 

  8. Sundqvist, M. et al. J. Antimicrob. Chemotherpy 65, 350– 360 (2010).

    Article  Google Scholar 

  9. Schneider, M., Harrison, N. R., Daniel, G. W. & McClellan, M. B. Delinking US Antibiotic Payments through a Subscription Model in Medicare (Duke-Margolis Center for Health Policy, 2020).

    Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links